FDA Revokes Emergency Use of Solo Bamlanivimab for COVID FDA Revokes Emergency Use of Solo Bamlanivimab for COVID

The manufacturer sought the withdrawal, noting that the monoclonal antibody is no longer effective alone against COVID-19.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Infectious Diseases News Source Type: news